Background

Osteoarthritis (OA) is a degenerative joint disorder that most commonly affects the knees and hip joints. It is the most common form of arthritis with an estimated prevalence of 302 million people worldwide [1,2,3,4]. Bearing in mind such high prevalence, it is considered one of the major contributors to chronic pain, disability, early retirement, and lost productivity among elder adults.

Patients suffering from OA are likely to be treated with a combination of pharmaceutical and non-pharmaceutical interventions. International guidelines recommend patient education and regular exercise as first-line treatment for OA due to the effectiveness of such approach in reducing pain and disability [5,6,7,8,9,10,11]. This was endorsed by the recently published American College of Rheumatology (ACR) recommendations for OA which strongly commends self-management, weight loss programmes, tai chi, cane use, tibiofemoral bracing, topical NSAIDs for knee OA and oral NSAIDs for knee, and/or hip OA. Intra-articular glucocorticoid injections for knee and/or hip OA have also been strongly recommended in the ACR guideline [12].

However, there is a paucity of literature documenting the implementation of guidelines for OA management into system-wide chronic care osteoarthritis programmes. The implementation of such multimodal, multidisciplinary programmes to manage this cohort of OA patients has not been widely reported or disseminated. In fact, treatment of OA requires a comprehensive management approach. This is expected to benefit the people suffering from such disorder as well as health providers by improving the provided quality of care and subside their use of health services.

To tackle the increasing burden of OA, osteoarthritis care programme (OACP) provides a pathway to improved care for people suffering from this rapidly growing chronic condition. The programme involves a strategy not only to better management of patients’ pain but also the comorbidities associated with their OA. This may support the potential of delaying or reducing their need for joint replacement surgery. In time, it is expected this approach will serve as a model of care to be implemented in other outpatient health services in accordance with local needs and resources. This article outlines the proposed programme which is applicable to standard practice.

Methodology

Given the broad and heterogeneous nature of the research questions to be addressed, a scoping review was considered the most appropriate methodological approach [13]. The working team formalised the research questions, searching for the relevant studies, agreeing on a strategy to select the relevant studies, charting the data, and finally collating, summarising, analysing, and presenting the results. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension for Scoping Reviews (PRISMA-ScR) checklist was used to guide the reporting of this review [14].

Main text

Objectives

Several reasons have been linked to the persistent evidence-practice gap in the management of OA. These include high volume of patients, socio-economic status, health schemes, infrastructure, health care professionals training, and health policies implemented [15]. The title “Model of Care” is used to outline the way clinical health services are delivered and is being progressively applied to musculoskeletal conditions [16]. A “Model of Care” can be defined as an “evidence-informed strategy, framework or pathway that outlines the optimal manner in which condition specific care should be delivered to consumers within a local health system” [17]. The aim of a “Model of Care” is to clearly operationalise evidence-based guidelines and consequently endorse the implementation of such management recommendations by healthcare professionals in their local health centres [16]. The objectives of this “Model of Care” for osteoarthritis are:

  1. 1.

    To set up and coordinate the inter-disciplinary, conservative management approach for patients diagnosed to have OA

  2. 2.

    To have an algorithm for patients’ management particularly aiming to reduce the level of pain and improve their quality of life and functional status

  3. 3.

    To endorse the value of patient education and self-management approach

Recognising the need to change

While there have been a growing number of “Model of Care” curricula published internationally for the management of OA [18,19,20], none have been published for local use in Egypt. Therefore, there was a vital need to formulate this programme based on the available evidence in the literature. Furthermore, understanding the principals of OA “Model of Care” is important to inform the services’ design for optimal care. Therefore, the need to change and set up this scoping review are:

  1. 1.

    There is no national Action Plan for the management of Osteoarthritis.

  2. 2.

    Current OA management is based on single practitioner or episodic care. Currently, there is no model of care available for care of OA patients within the context of chronic disease management.

  3. 3.

    There are no current services provided to help patients improve their muscle power or reduce weight. The value of such approaches was evidenced by a large prospective cohort study which revealed that almost 70% of knee replacements are attributed to or associated with over-weight [21]. In addition, another study revealed that approximately 25–50% of all knee replacements could be avoided, if all overweight and obese people reduced their weight by 5kg, or to within the normal body mass index (BMI) range [22].

Patients: case identification and access to the programme

In the context of this work, model of care has been developed for adults and older adults diagnosed to have OA. For the purpose of this work, inclusion was only restricted to the hip and knee joints’ primary OA. Diagnosis may be based on clinical assessment and radiographic criteria. Access to the programme can be outlined as follows:

  • Once it is settled that a chronic care management programme is indicated for an individual’s OA, he/ she can be referred to the service. OA patients can be referred by any healthcare professional, or by self-referral.

  • OA patients (Knee or hip joints) will be considered eligible for the programme, if they meet two clinical criteria:

    • Their knee and/or hip pain has been persistent on most of the days of the last month.

    • Pain score using Visual Analogue Scale (VAS) is at least 4/10 at the first assessment.

  • Exclusion criteria for participation are history of hip fracture or total joint replacement within the past 12 months, or hip/ knee surgery within the past 6 months, untreated ligamentous injury, suspicion of tumour, inflammatory arthritis (e.g. rheumatoid arthritis, psoriatic arthritis), infectious and crystalline arthritis (gout and pseudogout), fibromyalgia, and chronic pain disorders.

  • For participants whose reported level of pain is below the VAS threshold, alternatives to OA management will be offered including simple analgesia, self-management as well as exercise programmes.

  • For all the OA patients whether included in the programme or not, special consideration will be given to the presence of modifiable risk factors for OA progression, such as obesity and poor muscle strength and control.

Case manager

The Rheumatology and Rehabilitation specialist will act as case manager for these OA patients referred to the programme with a view towards facilitating comprehensive management and improving the patients’ health- related quality of life abilities as well as self-management skills.

Patient-centred coordination of care

The level of coordination should be tailored to the individual patient’s needs and both medical and physical status. The patient’s problem may be primarily musculoskeletal or linked to an associated comorbidity or the individual psychosocial requirements.

All the patients included will have an initial face-to-face assessment where thorough medical examination will be carried out to assess their physical health, disease severity, quality of life, and psychological status as well as any existing co-morbidities. Based on this initial assessment, the appropriate management plan for the delivery of care will be identified and agreed with the individual patient.

Clinical indicators

  • Demographic data, marital status, occupation, and education level.

  • Clinical disease activity: active synovitis, mechanical derangement, hypermobility, meniscal damage, and ligament injury.

  • Disease severity assessment:

  • Knee and hip radiographs are assessed with Kellgren and Lawrence grading system [23]. Knee radiographs should be performed with the patient standing to reveal joint space narrowing, while weight bearing is not necessary for hip radiographs which include anteroposterior and lateral views.

  • US assessment to evaluate joint and periarticular abnormalities [24].

  • Assessment of functional disability using: Knee injury and osteoarthritis outcome score (KOOS) [25] and hip disability and osteoarthritis outcome score (HOOS) [26].

  • Health-related quality of life (QoL), psychological status using patient-reported outcome measures (PROMs) questionnaire [27].

  • Sarcopenia screening: SARC-F questionnaire [28]

  • Lab tests: vitamin D

  • Muscle power/sarcopenia measures (time up and go, chair stand tests [TUG], 400-m walk) [29].

  • Modifiable risk factors, comorbidity data.

Goals of the programme

Several goals have been identified for the management of OA patients; these include:

  • Manage and control of the patient’s symptoms including both pain and stiffness.

  • Optimise the patient’s functional ability

  • Optimise the patient’s quality of life

  • Slow the progression of the disease

  • Reduce the impact of the associated modifiable risk factors

  • Control the associated comorbidity(ies)

Principles of management

Putting principles into practice is vital to be able to achieve the goals of the programme set above, and secure optimum control of the patients’ symptoms as well as optimum functional ability and quality of life. These include:

  • Provide a systematic approach to osteoarthritis management

  • Endorse self-management

  • Set up a programme for weight reduction

  • Facilitate psychological management

  • Engagement in an appropriate exercise programme

  • Disease management patient education

Multidisciplinary intervention

As there is no single treatment that can be considered adequate/satisfactory for managing OA, a multifaceted approach has been agreed upon as the best strategy for managing this cohort of population (Fig. 1). Such a strategy involves both nonpharmacological and pharmacological therapies. These have been strongly recommended [12] particularly for OA affecting the weight-bearing joints, where mechanics and lifestyle play a major role in shaping the patients’ symptoms.

  • Non-pharmacological therapies:

    • Physiotherapy

    • Occupational therapy

    • Psychological support

  • Pharmacological therapies:

    • Review of medications

    • Pain management

    • Visco-supplement therapy

Fig. 1
figure 1

Multifaceted approach to the assessment and management of OA patients

Surgical referral

Acceleration to surgical intervention should be considered for aggressive/severe non-responsive cases whose disease progress over a relatively short period and is impacting negatively on the patient’s physical and mental status.

Documentation and data recording

Collecting datasets are essential for conducting post hoc analyses to inform approaches to OA management. Therefore, data will be collected prospectively for every patient including:

  • Every patient will complete a baseline patient-reported outcome measurement questionnaire.

  • Baseline patient’s body weight, height, BMI, BP, and basic lab tests are recorded.

  • The patient-centred management as well as discharge plan will be recorded.

  • Every patient will have a regular face-to-face review to monitor his/her progress and discuss the implementation of self-management approaches.

  • PROMs scores will be recorded before discharge.

  • Scores/lab measures reflecting the control of the associated comorbidity(ies) will be recorded.

Key performance indicators

Key performance indicators (KPI) are a pertinent part of measuring the successes and failures of the service provided. Knowing and measuring the right KPIs are important as it gives a value to compare against the current performance, hence helping to evaluate the outcomes faster. KPIs clearly demonstrate whether or not the targeted goals have been reached. Implementing KPIs as a standard in the service means that goals can be set, a strategy is devised to reach these goals, and evaluate performance along the way of implementing the programme. The KPI can be summarised as follows:

  • Percentage of the OA patients assessed and have a management plan agreed in relation to the total patients referred to the service.

  • Percentage of the patients who have already started their recommended management plan within 3 months of baseline valuation (cut off point documenting objective success will be 80%).

  • Percentage of the patients (measured as a proportion of KPI 1) who have completed their recommended management plan at 12 months of baseline valuation (objective success will be 80%).

Primary outcome

To reduce the level of pain, improve symptoms, prevent disability, and improve the quality of life of OA patients.

Secondary outcome

To ensure timely access to joint replacement treatment and ensure that the patient receives pre-surgery rehabilitation programme.

Discussion

With the increasing number of older population worldwide and the growing incidence of obesity, the burden of osteoarthritis (OA) is expected to upsurge. However, the understanding of the ailment remains limited, and there are indications that there is an evidence-practice gap in OA management and that several patients living with the disease are receiving suboptimal medical care. Furthermore, despite its high prevalence and negative impact on people’s health-related quality of life, it is frequently overlooked in both global as well as national strategic plans for chronic disease management. In fact, OA is more than just a “wear and tear” cartilage pathology. It is a disorder that involves the whole joint, which is an organ in its own. OA is therefore considered an organ “joint” failure. The joint is a complex of various structures, including cartilage, bone, synovial membrane, muscles, nerves, and ligaments. Therefore, the consequences of its failure will expand beyond the limits of degeneration to include inflammation, bone deformity, and mechanical as well as neurological dysfunction. The growing healthcare utilisation and cost of joint replacement make the current socioeconomic impact of OA unsustainable and represent a major worldwide challenge [30, 31]. Therefore, when considering OA management, a “paradigm shift” is highly required to replace of the current “episodic care” implemented in standard practice. This highlights the value of having such multidisciplinary “models of care” for OA to be implemented in the day-to-day medical care. Such approach is expected to indorse the evidence-informed OA management and addresses the underutilised and underemphasised core recommended therapeutic approaches.

In conclusion, this scoping review has developed a “Model of Care” for people living with OA which can be implemented in standard practice. The results will give insight into the features, performance, results, and outcome measures assessed. It will also guide future research towards how “Model of Care” can be patient-centred and tailored to the individual medical status.